Skip to main content
main-content

Editor's pick

02-12-2020 | Prostate cancer | News

Androgen receptor inhibitors implicated in fall, fracture risk in prostate cancer

Treatment with androgen receptor inhibitors is associated with an increased risk for falls and fractures in men with prostate cancer, show findings from a meta-analysis.

25-11-2020 | Tyrosine kinase inhibitors | News

Bleeding risk doubled during concurrent VEGFR–TKI, anticoagulant therapy

The risk for clinically significant bleeding during concurrent treatment with VEGFR–tyrosine kinase inhibitors and factor Xa inhibitors is doubled when compared with factor Xa inhibitors alone, research shows.

18-11-2020 | Lung cancer | Highlight | News

Lung cancer screening adherence rates suboptimal in real-world studies

Real-world lung cancer screening rates are generally much lower than those reported in randomized controlled trials, particularly when shorter screening intervals are used, US study findings indicate.

San Antonio Breast Cancer Symposium 2020

Breaking news and expert video interviews on the latest data from the upcoming virtual meeting

Latest from across the site

04-12-2020 | FDA | News

FDA approves first PSMA-targeted radiotracer

More details about this decision available here

04-12-2020 | Breast cancer | News

SOLAR-1: OS data support PFS findings for fulvestrant plus alpelisib

Adding alpelisib to fulvestrant improves overall survival in people with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer, but not significantly so, show data from the phase 3 SOLAR-1 trial.

03-12-2020 | COVID-19 | News

Clinical guidance may impact cancer treatment rates during COVID-19

The number of people initiating systemic cancer therapies fell substantially at the start of the COVID-19 pandemic but then recovered rapidly with the implementation of new treatment guidance, UK study data show.

02-12-2020 | Prostate cancer | News

Androgen receptor inhibitors implicated in fall, fracture risk in prostate cancer

Treatment with androgen receptor inhibitors is associated with an increased risk for falls and fractures in men with prostate cancer, show findings from a meta-analysis.

01-12-2020 | Dietary supplementation | News

Vitamin D supplementation may reduce advanced cancer risk

Vitamin D supplementation is associated with a reduced risk for metastatic or fatal cancer, but the benefit appears to be largely restricted to people with normal BMI, shows an analysis of VITAL study data.

30-11-2020 | Breast cancer | News

No benefit of indoximod for HER2-negative metastatic breast cancer

The addition of indoximod to taxane chemotherapy does not improve the outcomes of patients with HER2-negative metastatic breast cancer, research suggests.

Meet the Editorial Board


Our international Editorial Board members Dr Fiona Blackhall (Christie Hospital, Manchester, UK) and Dr Axel Merseburger (University Hospital Schleswig-Holstein, Germany) work closely with the editorial team to highlight gaps in coverage and select topics to feature on this digital platform.

Why register? Medicine Matters oncology is a free resource providing the latest news and clinical guidance

Register today and receive updates directly to your inbox!
Medicine Matters oncology has been specifically developed for the time-limited healthcare professional who is looking for a single resource providing credible information on current practice and the latest advances in oncology.
Already registered? Log in now to unlock your access.

New Content Item Meet our Advisory Board

Image Credits